DOI:
10.1055/s-00044025
Annals of the National Academy of Medical Sciences (India)
LinksClose Window
References
Roep BO, Peakman M.
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes.
Nat Rev Immunol 2010;
10 (02) 145-152
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.